Clinical trial
Intravenous Immune Globulin Treatment Compared to Placebo in Patients With…
NCT00306033 · University Health Network, Toronto, Other · Completed
Key facts
| NCT number | NCT00306033 |
|---|---|
| Title | Intravenous Immune Globulin Treatment Compared to Placebo in Patients With Myasthenia Gravis |
| Official title | IVIG Treatment Compared to Placebo in Patients With Myasthenia Gravis: A Randomized Clinical Trial |
| Lead sponsor | University Health Network, Toronto, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Myasthenia Gravis |
| Intervention type | Drug |
| Interventions | Intravenous ImmuneGlobulin |
| Enrollment | 50 |
| Start date | Mar 1, 2004 |
| Completion | May 1, 2005 |
| First posted | Mar 22, 2006 |
| Last update posted | Apr 3, 2006 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: